BTNL2 gene SNPs as a contributing factor to sarcoidosis pathogenesis in a cohort of Greek patients

Meta Gene

Volumn 2, Issue , 2014, Pages 619-630

  Delaveri, Aikaterini ^a   Rapti, Aggeliki ^b   Poulou, Myrto ^a   Fylaktou, Eirini ^a   Tsipi, Maria ^a   Roussos, Charis ^b   Makrythanasis, Periklis ^a,c   Kanavakis, Emmanuel ^a,d   Tzetis, Maria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

BTNL2; Mutations; Sarcoidosis; SNPs

Indexed keywords

CYTOKINE;

ADULT; AGED; ALLELE; ARTICLE; BUTYROPHYILLIN LIKE 2 GENE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GREEK (PEOPLE); HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL;

EID: 84916225295     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2014.07.009     Document Type: Article

References (35)

1. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Agostini C., Adami F., Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr. Opin. Rheumatol. 2000, 12:71-76.
3. Choi Y., Sims G.E., Murphy S., Miller J.R., Chan A.P. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012, 7:e46688.
4. Cooper D.N., Krawczak M., Polychronakos C., Tyler-Smith C., Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum. Genet. 2013, 132:1077-1130.
5. Costabel U. Sarcoidosis: clinical update. Eur. Respir. J. Suppl. 2001, 56s-68s.
6. Costabel U., Hunninghake G.W. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur. Respir. J. 1999, 14:735-737.
7. Ferrer-Costa C., Orozco M., de la Cruz X. Sequence-based prediction of pathological mutations. Proteins 2004, 57:811-819.
8. Grubic Z., Peros-Golubicic T., Stingl K., Zunec R. The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians. Vasc. Lung Dis. 2011, 28:18-26.
9. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin. Respir. Crit. Care Med. 2010, 31:380-389.
10. Grunewald J., Brynedal B., Darlington P., Nisell M., Cederlund K., Hillert J., Eklund A. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir. Res. 2010, 11:25.
11. Grunewald J., Idali F., Kockum I., Seddighzadeh M., Nisell M., Eklund A., Padyukov L. Major histocompatibility complex class II transactivator gene polymorphism: associations with Löfgren's syndrome. Tissue Antigens 2010, 76:96-101.
12. Hunninghake G.W., Costabel U., Ando M., Baughman R., Cordier J.F., du Bois R., Eklund A., Kitaichi M., Lynch J., Rizzato G., Rose C., Selroos O., Semenzato G., Sharma O.P. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Vasc. Diffuse Lung Dis. 1999, 16:149-173.
13. Iannuzzi M.C. Advances in the genetics of sarcoidosis. Proc. Am. Thorac. Soc. 2007, 4:457-460.
14. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 2007, 357:2153-2165.
15. Li Y., Wollnik B., Pabst S., Lennarz M., Rohmann E., Gillissen A., Vetter H., Grohe C. BTNL2 gene variant and sarcoidosis. Thorax 2006, 61:273-274.
16. Lopez Herraez D., Martinez-Bueno M., Riba L., Garcia de la Torre I., Sacnun M., Goni M., Berbotto G.A., Paira S., Musuruana J.L., Graf C.E., Alvarellos A.J., Messina O.D., Babini A.M., Strusberg I., Marcos J.C., Scherbarth H., Spindler A.J., Quinteros A., Toloza S.M., Moreno J.L., Catoggio L.J., Tate G., Eimon A., Citera G., Catalan Pellet A., Nasswetter G.G., Cardiel M.H., Miranda P., Ballesteros F., Esquivel-Valerio J.A., Maradiaga-Cecena M.A., Acevedo-Vasquez E.M., Garcia Garcia C., Pons-Estel B.A., Alarcon-Riquelme M.E. Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region. Arthritis Rheum. 2013, 65:1457-1467.
17. Lynch J.P., Fishbein M.C., Saggar R., Zisman D.A., Belperio J.A. Idiopathic pulmonary fibrosis. Expert. Rev. Respir. Med. 2007, 1:377-389.
18. Mehta D., Lubitz S.A., Frankel Z., Wisnivesky J.P., Einstein A.J., Goldman M., Machac J., Teirstein A. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008, 133:1426-1435.
19. Mitsunaga S., Hosomichi K., Okudaira Y., Nakaoka H., Kunii N., Suzuki Y., Kuwana M., Sato S., Kaneko Y., Homma Y., Kashiwase K., Azuma F., Kulski J.K., Inoue I., Inoko H. Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2. J. Hum. Genet. 2013, 58:210-215.
20. Morais A., Lima B., Peixoto M.J., Alves H., Marques A., Delgado L. BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis. Respir. Med. 2012, 106:1771-1777.
21. Ng P.C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31:3812-3814.
22. Nguyen T., Liu X.K., Zhang Y., Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J. Immunol. 2006, 176:7354-7360.
23. Nunes H., Soler P., Valeyre D. Pulmonary sarcoidosis. Allergy 2005, 60:565-582.
24. Nunes H., Bouvry D., Soler P., Valeyre D. Sarcoidosis. J Rare. Dis. 2007, 2:46.
25. Raponi M., Kralovicova J., Copson E., Divina P., Eccles D., Johnson P., Baralle D., Vorechovsky I. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Hum. Mutat. 2011, 32:436-444.
26. Rose A.S., Tielker M.A., Knox K.S. Hepatic, ocular, and cutaneous sarcoidosis. Clin. Chest Med. 2008, 29:509-524. ix.
27. Rybicki B.A., Iannuzzi M.C., Frederick M.M., Thompson B.W., Rossman M.D., Bresnitz E.A., Terrin M.L., Moller D.R., Barnard J., Baughman R.P., DePalo L., Hunninghake G., Johns C., Judson M.A., Knatterud G.L., McLennan G., Newman L.S., Rabin D.L., Rose C., Teirstein A.S., Weinberger S.E., Yeager H., Cherniack R. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am. J. Respir. Crit. Care Med. 2001, 164:2085-2091.
28. Rybicki B.A., Hirst K., Iyengar S.K., Barnard J.G., Judson M.A., Rose C.S., Donohue J.F., Kavuru M.S., Rabin D.L., Rossman M.D., Baughman R.P., Elston R.C., Maliarik M.J., Moller D.R., Newman L.S., Teirstein A.S., Iannuzzi M.C. A sarcoidosis genetic linkage consortium: the Sarcoidosis Genetic Analysis (SAGA) study. Vasc. Diffuse. Lung Dis. 2005, 22:115-122.
29. Rybicki B.A., Walewski J.L., Maliarik M.J., Kian H., Iannuzzi M.C. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am. J. Hum. Genet. 2005, 77:491-499.
30. Saidha S., Sotirchos E.S., Eckstein C. Etiology of sarcoidosis: does infection play a role?. Yale J. Biol. Med. 2012, 85:133-141.
31. Smith G., Brownell I., Sanchez M., Prystowsky S. Advances in the genetics of sarcoidosis. Clin. Genet. 2008, 73:401-412.
32. Suzuki H., Ota M., Meguro A., Katsuyama Y., Kawagoe T., Ishihara M., Asukata Y., Takeuchi M., Ito N., Shibuya E., Nomura E., Uemoto R., Nishide T., Namba K., Kitaichi N., Morimoto S., Kaburaki T., Ando Y., Takenaka S., Nakamura J., Saeki K., Ohno S., Inoko H., Mizuki N. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest. Ophthalmol. Vis. Sci. 2012, 53:7109-7115.
33. Valentonyte R., Hampe J., Huse K., Rosenstiel P., Albrecht M., Stenzel A., Nagy M., Gaede K.I., Franke A., Haesler R., Koch A., Lengauer T., Seegert D., Reiling N., Ehlers S., Schwinger E., Platzer M., Krawczak M., Muller-Quernheim J., Schurmann M., Schreiber S. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 2005, 37:357-364.
34. Wijnen P.A., Voorter C.E., Nelemans P.J., Verschakelen J.A., Bekers O., Drent M. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression?. Hum. Immunol. 2011, 72:342-347.
35. Ziegenhagen M.W., Muller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J. Intern. Med. 2003, 253:18-30.